Trial · NCT05531955
Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
NCT05531955, Phase 2, Unknown, Shanghai Zhongshan Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction. Trials, record NCT05531955. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05531955
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
- NCT number
- NCT05531955
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Shanghai Zhongshan Hospital
- Conditions
- Myocardial Fibrosis
- Interventions
- Pirfenidone Oral Capsule, Placebo Oral Capsule
- First posted
- 2022-09-08
- Last updated
- 2022-11-10
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes of the subjects'ECV | 52week | Compare the ECV of subjects |
| Secondary | Cardiovascular death | 52week | Number of participants with cardiovascular death |
| Secondary | Admission for heart failure | 52week | Number of participants for heart failure |
| Secondary | Death | 52week | collect the case of death |
| Secondary | Changes of LVE | 52week | compare the LVEF of the subjects |
| Secondary | Changes of NT-proBNP | 52week | compare the NT-proBNP of the subjects |
| Secondary | Changes of ST2 | 52week | compare the ST2 of the subjects |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers9
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05531955
GET https://conductscience.org/api/trials/v1/NCT05531955/registered